MESCIUS USA, Inc., a global provider of award-winning enterprise software development tools, is pleased to announce the introduction of FlexDiagram for the ComponentOne product line. This latest ...

Despite negative equity, Amneal raised its operating cash flow guidance for FY25. Read why I agree with Wall St., which is ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. | Pharma and ...

Halliburton Company is rated a Buy despite recent share price underperformance and near-term industry headwinds. Learn more ...

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...

See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.

Background Fermented foods are a promising yet underexplored intervention for influencing brain function and mental health through the gut–brain axis. Objective The objective of this study was to ...

Discover how AI, flow chemistry, and NMR come together in the PiPAC project to revolutionize scalable and autonomous API ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

China recently blasted Britain over fresh delays to its controversial 'super embassy' – giving Starmer an ominous warning THE China spy trial collapsed because of a “shambolic” evidence process, an ...

Worse, the most recent CERN implementation of the FPGA-Based Level-1 Trigger planned for the 2026-2036 decade is a 650 kW system containing an incredibly high number of transistor, 20 trillion in all, ...

Escalating pressures in clinical trials are amplifying long-standing issues related to growing complexity, costs, and extended timelines, putting greater burdens on sponsors, sites, and patients. The ...